Browse studies
Find your next paid study
278 recruiting studies matching your filters
Phase 1
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas (LA-HNSCC)
The goal of this clinical trial is to learn if drug CADI-05, when used together with pembrolizumab (an FDA approved immunotherapy), can help treat locally adva…
Squamous Cell Carcinoma of Head and Neck
Estimated
~$10 – $6,250
Fox Chase Cancer CenterNCT07455032
Phase 2
A Phase II Study of Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
The purpose of this study is to assess the objective response rate following neoadjuvant therapy with volrustomig, paclitaxel, and carboplatin in previously un…
Head and Neck CancerHPV
Estimated
~$10 – $6,250
University of ChicagoNCT07065630